Health:Further

Vic interviews his friend Grant Chamberlain, Senior Managing Director, Healthcare Investment Banking at Ziegler. Grant has over 30 years of investment banking experience and has dedicated the majority of his career to advising HCIT and tech-enabled outsourced services companies with particular focus on transactions with telehealth companies.------🔎RESOURCES🔎ZIEGLER TELEHEALTH INDUSTRY RESEARCH: PART IV // https://www.ziegler.com/telehealth-part-iv/GRANT CHAMBERLAIN - LINKEDIN // https://www.linkedin.com/in/grant-chamberlain-14430099/------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

The Fed’s regulatory chief recently weighed in on a path to improvement following a string of midsize bank failures. Eli Lilly’s Retatrutide medication was recently under the WSJ spotlight for its surprising results. Rite Aid’s stock just hit a record low. We’re discussing these topics and more in Episode 11.------🔎RESOURCES🔎CPI REPORT // https://www.bls.gov/news.release/pdf/cpi.pdf ADP JOBS REPORT // https://adpemploymentreport.com/JOLTS REPORT // https://www.bls.gov/news.release/jolts.nr0.htmREDBOOK RETAIL REPORT // https://tradingeconomics.com/united-states/redbook-indexBANKS ARE GOING TO NEED MORE CAPITAL (WSJ) // https://on.wsj.com/3pNXG5eLILLY'S RETATRUTIDE SHOWS BENEFITS ON FATTY LIVER DISEASE (WSJ) // https://bit.ly/3XRDyLXRITE-AID DEBT CONCERNS (MARKETWATCH) // https://bit.ly/3rAYlasMARCUS WHITNEY: BANKING STRUGGLES ARE LIMITING HEALTHCARE INNOVATION (HFMA) // https://bit.ly/44J4gZo------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Marcus interviews his fellow national HFMA board member, Dave Johnson, founder and CEO of 4Sight Health. Dave is a prolific writer on healthcare's pro-market transformation. He is the author-in-residence at MATTER, the Chicago-based healthcare incubator, and published the critically acclaimed book Market vs. Medicine: America's Epic Fight for Better, Affordable Healthcare in 2016. McGraw-Hill published Dave's book The Customer Revolution in Healthcare: Delivering Smarter, Kinder, Affordable Care for All in September 2019.------🔎RESOURCES🔎4SIGHT HEALTH // https://www.4sighthealth.com/DAVE ON HFMA // https://www.hfma.org/author/david-johnson/------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

SCOTUS has rejected use of race in higher education, which brings up a reflection on what we learned during the pandemic and the result of compounding generational discrimination. A new MDMA PTSD treatment is on the rise, while the health value of Ozempic use is being questioned. We’re covering these topics and more in Episode 9.------🔎RESOURCES🔎SCOTUS DECISION // https://bloom.bg/3r1UfrIMAPS RAISING $85M FOR MDMA TREATMENT // https://on.wsj.com/3PBDOg4MAPS B CORP SITE // https://mapsbcorp.com/OZEMPIC: THIN BUT NOT NECESSARILY HEALTHY // https://on.wsj.com/3pv1xUA------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Vic Gatto and Marcus Whitney cover an array of trending topics including the Aledade capital raise, the letter from Senators Warren and Welch to Amazon regarding Amazon Clinic, the ASGE AI Task Force, and more.------🔎RESOURCES🔎ALEDADE CAPITAL RAISE // https://www.finsmes.com/2023/06/aledade-raises-260m-in-series-f-financing.html AMAZON CLINIC HOMEPAGE // https://amzn.to/3XufYENAMAZON DATA & PRIVACY WASHINGTON POST // https://www.washingtonpost.com/technology/2023/05/01/amazon-clinic-hipaa-privacy/ LETTER FROM SENATORS WARREN AND WELCH TO AMAZON // https://politi.co/3r3auF2 ASPEN IDEAS: HEALTH SCHEDULE // https://www.aspenideas.org/schedule AI OVERRIDES NURSE JUDGMENT WSJ // https://on.wsj.com/431npob AMERICAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY FORMS AI TASK FORCE TO USE AI BUT “KEEP THE GUARDRAILS ON” // https://bit.ly/3NPC9SM ASGE AI TASK FORCE // https://bit.ly/3NtneMT------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Vic Gatto and Marcus Whitney are joined by special guest Aaron Gani from BehaVR, Inc. for a discussion on the Digital Therapeutics space. We're also covering the "hawkish" Fed pause, a sign of increasing patient volumes from UHG, and more.------🔎RESOURCES🔎BEHAVR // https://www.behavr.com/DIGITAL THERAPEUTICS ALLIANCE // https://dtxalliance.org/ALLISON BARR ALLEN - TWITTER // https://twitter.com/abarrallenCPI SUMMARY FROM US BUREAU OF LABOR STATISTICS // https://www.bls.gov/news.release/cpi.nr0.htmFRED - BANK TERM FUNDING PROGRAM // https://fred.stlouisfed.org/series/H41RESPPALDKNWWWESTFIELD SAN FRANCISCO CENTRE - OWNER WALKS AWAY // https://on.wsj.com/3r0a2YaUHG PRESS RE INCREASING COSTS // https://bit.ly/3Jxz8nK------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Vic Gatto and Marcus Whitney discuss the Sequoia Capital split, the NEDA Chatbot mishap, Optum's bid for Amedisys, and more.------🔎RESOURCES🔎SEQUOIA BREAKUP WSJ // https://on.wsj.com/3qSRHvZHOW A CHATBOT WENT ROGUE WSJ // https://bit.ly/3NoVSr7FERTILITY STARTUP BUNNII SHUTTERS // https://bit.ly/43ZCoAuOPTUM BIDDING FOR AMEDISYS (FIERCE) // https://bit.ly/3Jx5Gyf------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/------📱FOLLOW HEALTH:FURTHER SOCIALS📱INSTAGRAM // https://www.instagram.com/healthfurther/TWITTER // https://twitter.com/HealthFurtherFACEBOOK // https://www.facebook.com/HealthFurther/LINKEDIN // https://www.linkedin.com/company/health-furtherTIKTOK // https://www.tiktok.com/@healthfurtherYOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKwHF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Vic Gatto and Marcus Whitney cover recent trending topics in healthcare including the Theranos scandal, CommonSpirit’s quarterly report, VC news from WSJ, the PCE index increase, and more.HF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Vic Gatto and Marcus Whitney explore the recent sale of Pear Therapeutics and what this situation means for the road ahead in the digital therapeutics space. Also included in the discussion is an in-depth look at a recent call to action from Andreessen Horowitz.HF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK

Vic Gatto and Marcus Whitney discuss recent developments in healthcare including details around the KKR/Envision bankruptcy situation, the debt ceiling crisis, advancements in AI tech and impact on healthcare, and more.HF SiteYOUTUBEINSTAGRAMTWITTERFACEBOOKLINKEDINTIKTOK